These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 31882426

  • 1. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
    Li X, Yan Z, Tian J, Zhang X, Han H, Ye F.
    Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426
    [Abstract] [Full Text] [Related]

  • 2. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid.
    Jiao L, Wang R, Dong Y, Su J, Yu J, Yan M, Chen S, Lv G.
    J Ethnopharmacol; 2024 Oct 28; 333():118488. PubMed ID: 38925319
    [Abstract] [Full Text] [Related]

  • 3. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y, Zhao Z, Li Y, Yang Y, Li L, Jiang Y, Lin C, Cao Y, Zhou P, Tian Y, Wu T, Pang J.
    Phytomedicine; 2021 Jan 28; 80():153374. PubMed ID: 33075645
    [Abstract] [Full Text] [Related]

  • 4. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO, Ohtomo S, Kiyokawa J, Nakagawa T, Yamane M, Lee KJ, Kim KH, Kim BH, Tanaka J, Kawabe Y, Horiba N.
    J Pharmacol Exp Ther; 2016 Apr 28; 357(1):157-66. PubMed ID: 26907620
    [Abstract] [Full Text] [Related]

  • 5. Hypouricemic Effects of Extracts from Urtica hyperborea Jacq. ex Wedd. in Hyperuricemia Mice through XOD, URAT1, and OAT1.
    Han S, Wei R, Han D, Zhu J, Luo W, Ao W, Zhong G.
    Biomed Res Int; 2020 Apr 28; 2020():2968135. PubMed ID: 32083126
    [Abstract] [Full Text] [Related]

  • 6. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
    Tan PK, Liu S, Gunic E, Miner JN.
    Sci Rep; 2017 Apr 06; 7(1):665. PubMed ID: 28386072
    [Abstract] [Full Text] [Related]

  • 7. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
    Hu Q, Zhou M, Zhu H, Lu G, Zheng D, Li H, Hao K.
    Biomed Pharmacother; 2017 Feb 06; 86():88-94. PubMed ID: 27951420
    [Abstract] [Full Text] [Related]

  • 8. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.
    Zhang Y, Jin L, Liu J, Wang W, Yu H, Li J, Chen Q, Wang T.
    J Ethnopharmacol; 2018 Mar 25; 214():29-36. PubMed ID: 29233733
    [Abstract] [Full Text] [Related]

  • 9. Saponins extracted from Dioscorea collettii rhizomes regulate the expression of urate transporters in chronic hyperuricemia rats.
    Zhu L, Dong Y, Na S, Han R, Wei C, Chen G.
    Biomed Pharmacother; 2017 Sep 25; 93():88-94. PubMed ID: 28624426
    [Abstract] [Full Text] [Related]

  • 10. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
    Li Y, Zhao Z, Luo J, Jiang Y, Li L, Chen Y, Zhang L, Huang Q, Cao Y, Zhou P, Wu T, Pang J.
    Phytomedicine; 2021 Jul 25; 87():153585. PubMed ID: 34044255
    [Abstract] [Full Text] [Related]

  • 11. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.
    Tan PK, Farrar JE, Gaucher EA, Miner JN.
    Mol Biol Evol; 2016 Sep 25; 33(9):2193-200. PubMed ID: 27352852
    [Abstract] [Full Text] [Related]

  • 12. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice.
    Sun WF, Zhu MM, Li J, Zhang XX, Liu YW, Wu XR, Liu ZG.
    J Ethnopharmacol; 2015 Feb 23; 161():163-9. PubMed ID: 25535087
    [Abstract] [Full Text] [Related]

  • 13. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout.
    Hou Z, Ma A, Mao J, Song D, Zhao X.
    Expert Opin Drug Metab Toxicol; 2023 Dec 23; 19(12):895-909. PubMed ID: 37994776
    [Abstract] [Full Text] [Related]

  • 14. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
    Hu QH, Zhang X, Wang Y, Kong LD.
    Yao Xue Xue Bao; 2010 Oct 23; 45(10):1239-46. PubMed ID: 21348301
    [Abstract] [Full Text] [Related]

  • 15. [Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats].
    Chen GL, Zhu LR, Na S, Li L.
    Zhongguo Zhong Yao Za Zhi; 2013 Jul 23; 38(14):2348-53. PubMed ID: 24199570
    [Abstract] [Full Text] [Related]

  • 16. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice.
    Wang CP, Wang X, Zhang X, Shi YW, Liu L, Kong LD.
    J Pharm Pharm Sci; 2010 Jul 23; 13(3):411-27. PubMed ID: 21092713
    [Abstract] [Full Text] [Related]

  • 17. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
    Zhao ZA, Jiang Y, Chen YY, Wu T, Lan QS, Li YM, Li L, Yang Y, Lin CT, Cao Y, Zhou PZ, Guo JY, Tian YX, Pang JX.
    Acta Pharmacol Sin; 2022 Jan 23; 43(1):121-132. PubMed ID: 33767379
    [Abstract] [Full Text] [Related]

  • 18. Anti-hyperuricemia effect of Clerodendranthus spicatus: a molecular biology study combined with metabolomics.
    Zhou Z, Xu M, Bian M, Nie A, Sun B, Zhu C.
    Sci Rep; 2024 Jul 04; 14(1):15449. PubMed ID: 38965392
    [Abstract] [Full Text] [Related]

  • 19. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.
    You W, Wang J, Zou Y, Che K, Hou X, Fei H, Wang Y.
    J Int Med Res; 2019 May 04; 47(5):1927-1935. PubMed ID: 30832523
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
    Taniguchi T, Ashizawa N, Matsumoto K, Saito R, Motoki K, Sakai M, Chikamatsu N, Hagihara C, Hashiba M, Iwanaga T.
    J Pharmacol Exp Ther; 2019 Oct 04; 371(1):162-170. PubMed ID: 31371478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.